Researcher
Ramanuj DasGupta is a Senior Principal Scientist at the A*STAR Genome Institute of Singapore (A*STAR GIS) where he led a programme in Precision Oncology and Cancer Evolution. He obtained his PhD degree in developmental and stem cell biology at the University of Chicago, US, followed by postdoctoral studies at Harvard Medical School, US, where he pioneered whole-genome high-throughput, RNAi-based functional genomic screens to identify novel regulators of cell-signalling pathways.
DasGupta is also a Professor of Cancer Systems Biology at the School of Cancer Sciences, University of Glasgow and the CRUK-Scotland Institute. The major focus of his laboratory is to interrogate the mechanistic basis for how damage-associated regenerative programmes in the intra-hepatic microenvironment drives progression of chronic disease to HCC.
Related Articles
Screening signatures of dodgy tumours
22 Apr 2026A new cellular model of colorectal cancer helps identify high-risk subtypes likely to resist standard
Tailoring treatments to fit our genes
6 Jan 2026A new precision oncology platform taps into machine learning to guide colorectal cancer treatments based
COVID-19’s far-reaching effects from lung to liver
30 Nov 2021Using single-cell sequencing technology, A*STAR scientists have identified a rare population of liver cells susceptible
Tumors hide by mimicking fetal characteristics
26 Apr 2021Liver tumors gain immune tolerance by activating cellular mechanisms involved in fetal development.
Poised for survival
16 Apr 2019State-of-the-art single-cell RNA sequencing technologies shed light on the mechanisms through which cancer cells become



